Prexion, Inc.
$31.5K 23 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Lupin Inc.
Lupin Inc. reported $31,528.92 across General Payments, Research, and Ownership to 12 physicians and teaching hospitals across 35 transactions.
- $31.5K Below-median payer
- All-tracks total
- 35 Below-median volume
- Transactions
- 12 Below-median reach
- Recipients
- +$24.2K
- General Payments vs PY2023
Lupin Inc. reported $31,528.92 across all CMS Open Payments tracks (General + Research + Ownership) to 12 physicians and teaching hospitals in Program Year 2024 - ranking #1458 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $30,382.00, averaging $2.6K per recipient.
How Lupin Inc.'s $31.5K all-tracks total breaks down
Lupin Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lupin-inc Lupin Inc.
$31.5K · #1458/1,925 · 0.0% industry · PY2024
- TOT $31.5K
- RANK #1458
- SHARE 0.0%
- TXN 35
- RCP 12
- CAT 1
- GEN $30.4K
- ΔGEN +$24.2K
- TOP1 12.8%
- PY 2024
Volume peers
Nearest volume peer: Prexion, Inc. ($31.5K)
Lupin Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Lupin Inc.'s CMS-reported General Payments increased by $24.2K (+389.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LUPIN INC.PY2023: LUPIN INC.PY2024: Lupin Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $6,210.00
- PY2024
- $30,382.00
What the Data Shows for Lupin Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Lupin Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Consulting Fee" leads the 1-category general-payment breakdown below at $30.4K (100.0% of General Payments, 12 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Consulting Fee" leads Lupin Inc.'s 1-category general-payment breakdown at $30.4K, 100.0% of the reported total.
How Lupin Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $30.4K | 12 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $17,741.00 (58.4%) of $30,382.00 in this company's General Payments records across 11 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lupin Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Peter Kang
$3,900.00 across 1 reported transactions
- 2
Chad Heatwole
$3,900.00 across 1 reported transactions
- 3
Justin Oldham
$3,766.00 across 2 reported transactions
- 4
Perry Shieh
$3,250.00 across 1 reported transactions
- 5
Matthew Wicklund
$2,925.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lupin Inc. ranks #1458 of 1,925 by total payments (bottom 24% by spend) but is notably more concentrated than that alone would suggest -- #1,025 of 1,838 by HHI (bottom 44% least concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Recor Medical Inc : $244.1K total payments, HHI 1026
- Bioprotect Medical, Inc. : $136.5K total payments, HHI 1025
- I/O Urology Corp. : $2.1K total payments, HHI 1025
- Cardinal Health 200 LLC : $63.8K total payments, HHI 1024
- Genesys Orthopedics Systems, L.L.C. : $837.2K total payments, HHI 1023
- Procyrion, Inc. : $53.4K total payments, HHI 1019
- Lupin Inc. (this company) : $30.4K total payments, HHI 1015
- Spectrum Pharmaceuticals Inc. : $38.7K total payments, HHI 1008
- Orthalign Inc : $1.5M total payments, HHI 1006
- Canon Medical Informatics, Inc. : $35.2K total payments, HHI 1001
- Ortho Systems : $2.4K total payments, HHI 1000
- TruAbutment Inc. : $204.0K total payments, HHI 999
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lupin Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lupin Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lupin Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Optos plc
$31.7K 31 recipients
Compare payment profiles
ProgenaCare Global, LLC
$31.3K 385 recipients
Compare payment profiles
Catheter Precision Inc.
$31.3K 40 recipients
Compare payment profiles
Vitrolife Inc.
$31.3K 38 recipients
Compare payment profiles
Atlas Spine, Inc.
$31.3K 17 recipients
Compare payment profiles
Put this to use
Lupin Inc. ranks #1458 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Lupin Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.